On October 10, 2017 Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) reported that it will release its third quarter 2017 financial results on Thursday, November 2, 2017 at 7:00 a.m. ET(Press release, Teva, OCT 10, 2017, View Source [SID1234520906]).

Teva will host a conference call and live webcast on the same day, at 8:00 a.m. ET to discuss its third quarter 2017 results and overall business environment. A Question & Answer session will follow this discussion.

In order to participate, please dial the following numbers (at least 10 minutes before the scheduled start time): United States 1-866-869-2321; Canada 1-866-766-8269 or International +44(0) 203 0095710; passcode: 91932782. For a list of other international toll-free numbers, click here.

A live webcast of the call will also be available on Teva’s website at: www.ir.tevapharm.com Please log in at least 10 minutes prior to the conference call in order to download the applicable audio software.

Following the conclusion of the call, a replay of the webcast will be available within 24 hours on the Company’s website. The replay can also be accessed until November 30, 2017, 9:00 a.m. ET by calling United States 1-866-247-4222; Canada 1-866-878-9237 or International +44(0) 1452550000; passcode: 91932782.

On October 10, 2017 Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology company developing novel oncology and drug-delivery therapies, reported that it will webcast its Quarterly Update Conference Call for the third quarter 2017 on Tues., Nov. 7 at 4:30 p.m. ET/1:30 p.m. PT (Press release, Halozyme, OCT 10, 2017, View Source [SID1234520908]). Dr. Helen Torley, president and chief executive officer, will lead the call. On the same date, Halozyme will release financial results for the third quarter 2017 following the close of trading.

The call will be webcast live through the “Investors” section of Halozyme’s corporate website and a recording will be made available following the close of the call. To access the webcast and additional documents related to the call, please visit the Investors page of www.halozyme.com approximately fifteen minutes prior to the call to register, download and install any necessary audio software. The live call may be accessed by dialing (877) 410-5657 (domestic callers) or (334) 323-7224 (international callers) using passcode 769890. A telephone replay will be available after the call by dialing (877) 919-4059 (domestic callers) or (334) 323-0140 (international callers) using replay ID number 19320711.

On October 10, 2017 Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) reported that the Company will report its financial results for the third quarter 2017 on Thursday, October 26, 2017 before the US financial markets open. Following the release of the financial results, Alexion management will conduct a conference call and audio webcast on Thursday, October 26, 2017, at 10:00 a.m. Eastern Time (ET) (Press release, Alexion, OCT 10, 2017, View Source [SID1234520909]).

To participate in this conference call, dial 877-723-9522 (USA) or 719-457-2615 (International), passcode 3433245 shortly before 10:00 a.m. ET. A replay of the call will be available from 1:00 p.m. ET through a limited time thereafter. The replay number is 888-203-1112 (USA) or 719-457-0820 (International), passcode 3433245. The audio webcast can be accessed on the Investor page of View Source

On October 10, 2017 Horizon Pharma plc (Nasdaq:HZNP), a biopharmaceutical company focused on improving patients’ lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs, reported that its third-quarter 2017 financial results will be released on Monday, Nov. 6, 2017. Following the announcement, Horizon’s management will host a live conference call and webcast at 8 a.m. Eastern Time to review the Company’s financial and operating results (Press release, Horizon Pharma, OCT 10, 2017, View Source [SID1234520910]).

The live webcast and a replay may be accessed at View Source Please connect to the Company’s website at least 15 minutes before the live webcast to ensure adequate time for any software download that may be needed to access the webcast. Alternatively, please call 1-888-338-8373 (U.S.) or 973-872-3000 (international) to listen to the conference call. The conference ID number for the live call is 96805714. Telephone replay will be available approximately two hours after the call. To access the replay, please call 1-855-859-2056 (U.S.) or 404-537-3406 (international). The conference ID number for the replay is 96805714.

On October 10, 2017 Acorda Therapeutics, Inc. (Nasdaq:ACOR) reported that it will host a conference call and webcast to report its third quarter 2017 financial results and pipeline updates on Tuesday, October 31 at 8:30 a.m. ET (Press release, Acorda Therapeutics, OCT 10, 2017, View Source [SID1234520911]).

To participate in the conference call, please dial (844) 579-6824 (domestic) or (763) 488-9145 (international) and reference the access code 95686626. The presentation will be available on the Investors section of www.acorda.com.

A replay of the call will be available from 11:30 a.m. ET on October 31, 2017 until 2:59 p.m. ET on November 30, 2017. To access the replay, please dial (855) 859-2056 (domestic) or (404) 537-3406 (international) and reference the access code 95686626. The archived webcast will be available in the Investor Relations section of the Acorda website at www.acorda.com.